Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
Tag: Third World and Developing Countries
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
Ecuador Moves to Expand Drilling in the Amazon
A novel idea to leave the country’s vast oil reserves in the ground fizzled for lack of international support. Now, struggling under painful debt, the government wants to expand drilling in the rainforest.
Epidemics That Weren’t: How Countries Shut Down Recent Outbreaks
Some of the most fragile health systems in the world can teach us ways to respond to public health threats early and effectively.
A Powerful Climate Leader From a Small Island Nation
Mia Mottley, the prime minister of Barbados, has been drawing attention to the environmental and financial threats faced by small and vulnerable countries like hers.
‘There Must Be More Room for Africa,’ Leader of African Union Says
President Macky Sall of Senegal, chairman of the bloc, said in an interview before the U.S.-Africa summit that it’s time for the continent to have more seats in global institutions.
Key Partner in Covax Will End Support for Middle-Income Nations
Many of the poorest countries will continue to get free Covid shots, but global demand for them has plummeted, driving a shift away from the goal of broad coverage.
Tiny Vanuatu Uses Its ‘Unimportance’ to Launch Big Climate Ideas
It wants a top international court to weigh in on whether nations are legally bound to protect against climate risks.
John Kerry Plans to Meet With Biden to Discuss His Future as Climate Envoy
In an interview, Mr. Kerry said he would meet with the president next week to talk about “the road ahead.”
Global Partners May End Broad Covid Vaccination Effort in Developing Countries
The board of Gavi, the international vaccine agency, meets Wednesday to debate shutting down the program, known as Covax, amid swiftly waning demand for the shots.